HCT Co., Ltd. (KOSDAQ:072990)
3,280.00
-215.00 (-6.15%)
At close: Jul 21, 2026
HCT Co., Ltd. Revenue
HCT Co., Ltd. had revenue of 24.72B KRW in the quarter ending March 31, 2026, a decrease of -3.71%. This brings the company's revenue in the last twelve months to 106.58B, up 6.40% year-over-year. In the year 2025, HCT Co., Ltd. had annual revenue of 107.53B with 13.90% growth.
Revenue (ttm)
106.58B
Revenue Growth
+6.40%
P/S Ratio
0.45
Revenue / Employee
208.56M
Employees
511
Market Cap
47.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 107.53B | 13.12B | 13.90% |
| Dec 31, 2024 | 94.41B | 20.29B | 27.38% |
| Dec 31, 2023 | 74.11B | 7.00B | 10.42% |
| Dec 31, 2022 | 67.11B | 3.84B | 6.08% |
| Dec 31, 2021 | 63.27B | 9.89B | 18.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| A-Tech Solution | 300.15B |
| Jin Yang Pharmaceutical | 122.15B |
| Inics | 120.20B |
| Samjin Food | 112.34B |
| Homecast | 102.10B |
| DAEJIN ADVANCED MATERIALS | 90.60B |
| Assems | 56.78B |
| SM Life Design Group | 55.81B |